Literature DB >> 26191306

T-cell lymphoma with von Hippel-Lindau disease: a rare case report and review of literature.

Li-Hong Lou1, Hua Shen1, Jun Lin2, Yi-Wen Yan1, Yan Peng1, Jian-Hong Lu1, Qu Xu1, Hai-Qiong Jiang1.   

Abstract

von Hippel-Lindau disease (VHLD) comprises a series of complicated clinical manifestations. We hereby described a unique case of co-existing T-cell lymphoma (TCL) and confirmed VHLD. The symptoms in this 42-year-old male included fever and pancytopenia. Overall tests and examination made an infectious process unlikely. The results of bone marrow biopsy confirmed the diagnosis. The purposes we described this case were to probe into the relationship between TCL and VHLD, which was not mentioned in previously literature. Combination of clinical, radiological, immunophenotypic, pathological, and genetic data plays an important role in improving the rate of diagnosis, particularly in the challenge for diagnosis of T cell non-Hodgkin lymphoma.

Entities:  

Keywords:  T-cell lymphoma; hematological neoplasm; von Hippel-Lindau disease

Mesh:

Year:  2015        PMID: 26191306      PMCID: PMC4503177     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

Review 1.  Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.

Authors:  Chi-Chao Chan; Atif Ben Daniel Collins; Emily Y Chew
Journal:  Retina       Date:  2007-01       Impact factor: 4.256

2.  The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.

Authors:  X Niu; T Zhang; L Liao; L Zhou; D J Lindner; M Zhou; B Rini; Q Yan; H Yang
Journal:  Oncogene       Date:  2011-07-04       Impact factor: 9.867

3.  Clinical features and natural history of von Hippel-Lindau disease.

Authors:  E R Maher; J R Yates; R Harries; C Benjamin; R Harris; A T Moore; M A Ferguson-Smith
Journal:  Q J Med       Date:  1990-11

4.  Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification.

Authors:  Sun Och Yoon; Cheolwon Suh; Dae Ho Lee; Hyun-Sook Chi; Chan Jeoung Park; Seong-Soo Jang; Hai-Rim Shin; Bong-Hee Park; Jooryung Huh
Journal:  Am J Hematol       Date:  2010-10       Impact factor: 10.047

Review 5.  Molecular basis of the VHL hereditary cancer syndrome.

Authors:  William G Kaelin
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

6.  Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas.

Authors:  K Amara; M Trimeche; S Ziadi; A Laatiri; M Hachana; S Korbi
Journal:  Ann Oncol       Date:  2008-06-06       Impact factor: 32.976

7.  Von Hippel-Lindau disease: a genetic study.

Authors:  E R Maher; L Iselius; J R Yates; M Littler; C Benjamin; R Harris; J Sampson; A Williams; M A Ferguson-Smith; N Morton
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

8.  Effects of the HIF1 inhibitor, echinomycin, on growth and NOTCH signalling in leukaemia cells.

Authors:  Satoru Yonekura; Mai Itoh; Yuki Okuhashi; Yusuke Takahashi; Aya Ono; Nobuo Nara; Shuji Tohda
Journal:  Anticancer Res       Date:  2013-08       Impact factor: 2.480

Review 9.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

Review 10.  What the neurosurgeon should know about hemangioblastoma, both sporadic and in Von Hippel-Lindau disease: A literature review.

Authors:  Sven Bamps; Frank Van Calenbergh; Steven De Vleeschouwer; Johannes Van Loon; Raf Sciot; Eric Legius; Jan Goffin
Journal:  Surg Neurol Int       Date:  2013-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.